HomeCompareCYBQF vs EQR

CYBQF vs EQR: Dividend Comparison 2026

CYBQF yields 116.28% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CYBQF wins by $7.37M in total portfolio value
10 years
CYBQF
CYBQF
● Live price
116.28%
Share price
$1.72
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7.42M
Annual income
$2,756,053.49
Full CYBQF calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — CYBQF vs EQR

📍 CYBQF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCYBQFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CYBQF + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CYBQF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CYBQF
Annual income on $10K today (after 15% tax)
$9,883.72/yr
After 10yr DRIP, annual income (after tax)
$2,342,645.47/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, CYBQF beats the other by $2,337,991.20/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CYBQF + EQR for your $10,000?

CYBQF: 50%EQR: 50%
100% EQR50/50100% CYBQF
Portfolio after 10yr
$3.73M
Annual income
$1,380,764.54/yr
Blended yield
36.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

CYBQF
No analyst data
Altman Z
2.8
Piotroski
2/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CYBQF buys
0
EQR buys
0
No recent congressional trades found for CYBQF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCYBQFEQR
Forward yield116.28%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$7.42M$47.8K
Annual income after 10y$2,756,053.49$5,475.61
Total dividends collected$6.72M$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CYBQF vs EQR ($10,000, DRIP)

YearCYBQF PortfolioCYBQF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$22,328$11,627.91$11,380$679.82+$10.9KCYBQF
2$48,155$24,264.19$13,014$837.25+$35.1KCYBQF
3$100,433$48,907.54$14,961$1,036.20+$85.5KCYBQF
4$202,794$95,329.78$17,297$1,289.22+$185.5KCYBQF
5$396,885$179,895.62$20,121$1,613.15+$376.8KCYBQF
6$753,705$329,038.76$23,561$2,030.84+$730.1KCYBQF
7$1,390,448$583,983.43$27,783$2,573.54+$1.36MCYBQF
8$2,494,642$1,006,861.95$33,013$3,284.39+$2.46MCYBQF
9$4,357,527$1,688,260.58$39,547$4,223.51+$4.32MCYBQF
10$7,418,607$2,756,053.49$47,791$5,475.61+$7.37MCYBQF

CYBQF vs EQR: Complete Analysis 2026

CYBQFStock

CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains equipment and systems for medical and warfare in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use in lower limb and single joint type; non-medical HAL for lower limb, single joint type, and lumbar type; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; and Acoustic X, a high speed light pulse LED array light source that enables real time photoacoustic imaging. It also provides Cybernics Treatment, a treatment that uses HAL to enhance/regenerate the function of the wearer for spinal cord injury, stroke, neuromuscular diseases, etc.; HAL FIT for enhancement of brain-nerve-musculoskeltal system; MTX Neuro HAL Plus to enhance the performance of the athletes' brain-nerve functions; and Neuro HALFIT for enhancement of physical functions. In addition, the company is involved in the provision of rescue supports in disaster sites, and heavy labor supports for factories and plants; and entertainment business. The company was incorporated in 2004 and is headquartered in Tsukuba, Japan.

Full CYBQF Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this CYBQF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CYBQF vs SCHDCYBQF vs JEPICYBQF vs OCYBQF vs KOCYBQF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.